Vertex Pharmaceuticals (VRTX) Enterprise Value Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.39% |
| Dec 31, 2025 | 15.05% |
| Sep 30, 2025 | 13.67% |
| Jun 30, 2025 | 11.64% |
| Mar 31, 2025 | 9.03% |
| Dec 31, 2024 | 6.68% |
| Sep 30, 2024 | 2.13% |
| Jun 30, 2024 | 4.76% |
| Mar 31, 2024 | -13.68% |
| Dec 31, 2023 | -18.99% |
| Sep 30, 2023 | -24.70% |
| Jun 30, 2023 | -27.27% |
| Mar 31, 2023 | -35.45% |
| Dec 31, 2022 | -41.45% |
| Sep 30, 2022 | -34.72% |
| Jun 30, 2022 | -32.80% |
| Mar 31, 2022 | -33.30% |
| Dec 31, 2021 | -33.42% |
| Sep 30, 2021 | -31.99% |
| Jun 30, 2021 | -34.79% |
| Mar 31, 2021 | -41.44% |
| Dec 31, 2020 | -47.50% |
| Sep 30, 2020 | -50.62% |
| Jun 30, 2020 | -54.69% |
| Mar 31, 2020 | -150.41% |
| Dec 31, 2019 | -44.85% |
| Sep 30, 2019 | -61.90% |
| Jun 30, 2019 | -64.73% |
| Mar 31, 2019 | -58.92% |
| Dec 31, 2018 | -52.76% |
| Sep 30, 2018 | -52.64% |
| Jun 30, 2018 | -46.95% |
| Mar 31, 2018 | -28.25% |
| Dec 31, 2017 | -14.95% |
| Sep 30, 2017 | -6.80% |
| Jun 30, 2017 | -6.50% |
| Mar 31, 2017 | 41.37% |
| Dec 31, 2016 | 5.08% |
| Sep 30, 2016 | 8.78% |
| Jun 30, 2016 | 14.04% |
| Mar 31, 2016 | 6.13% |
| Dec 31, 2015 | 7.54% |
| Sep 30, 2015 | 12.26% |
| Jun 30, 2015 | 10.03% |
| Mar 31, 2015 | -0.89% |
| Dec 31, 2014 | -18.19% |
| Sep 30, 2014 | -39.50% |
| Mar 31, 2014 | -17.16% |
| Dec 31, 2013 | -12.41% |
| Sep 30, 2013 | -1.03% |
| Jun 30, 2013 | -12.43% |
| Mar 31, 2013 | 1.40% |
| Dec 31, 2012 | 4.35% |
| Sep 30, 2012 | -31.11% |
| Jun 30, 2012 | -42.58% |
| Mar 31, 2012 | -23.32% |